Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Carson, Kenneth
Associate Professor
Bio
I have extensive research experience in the area of population health and outcomes research in oncology. My primary research interests have been in the use of large datasets to understand clinical and... [more]
Catalona, William J.
Professor
Bio
Conducting research into the genetics of prostate cancer which could lead to new tests for the disease as well as possible new means of treating or preventing prostate cancer
Chae, Young Kwang
Associate Professor
Bio
Personalized Cancer Therapy, Precision Medicine, Early Phase Clinical Trials, First-in-Human Study, Novel Combination Cancer Therapy, Targeted therapy, Immunotherapy, Biomarker Study, Novel Drug Devel... [more]
Chandra, Sunandana
Associate Professor
Bio
Studying novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other advanced skin cancers, as well as cancer of unknown primary.
Chang, Catalina Lee
Assistant Professor
Bio
My research is focused in elucidating fundamental aspects of primary brain tumors immunology. As neuroimmunologist by training, I am passionated to understand the inter-relationship within the immune ... [more]
Chaudhury, Sonali
Professor
Bio
I am a pediatric stem sell transplanter with special interest in transplantation strategies to reduce toxicities, stem cell transplants for non-malignant disorders utilizing reduced intensity transpl... [more]
Chawla, Akhil
Assistant Professor, Clinical
Bio
Dr. Chawla is a Hepatopancreatobiliary and Gastrointestinal Surgical Oncologist at Northwestern Medicine, Clinical Assistant Professor at Northwestern University Feinberg School of Medicine, and membe... [more]
Chen, Yi-Hua
Professor
Bio
Hematopathology Diagnostic and prognostic markers for lymphoma and leukemia.
Cheng, Shi-Yuan
Professor
Bio
The primary goal of our research is to improve our understanding of molecular mechanisms of cancer tumorigenesis, invasion, metastases and angiogenesis, and to translate our novel discoveries to clini... [more]
Choi, Jaehyuk
Associate Professor
Bio
We study incurable skin cancers with a primary focus on cutaneous T cell lymphoma. We are using human and animal models with two goals. We seek to determine 1) the molecular basis of the aberrant... [more]